Madrigal Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US5588681057

SecurityMDGL / Madrigal Pharmaceuticals, Inc.
InstitutionD. E. Shaw & Co., Inc.
ManagerDE Shaw
Latest Disclosed Ownership30,139 shares
Latest Disclosed Value $ 15,776,863
D. E. Shaw & Co., Inc. ownership in MDGL / Madrigal Pharmaceuticals, Inc.

On May 15, 2026 - D. E. Shaw & Co., Inc. filed a 13F-HR form disclosing ownership of 30,139 shares of Madrigal Pharmaceuticals, Inc. (US:MDGL) valued at $15,776,862 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 88,554 shares of Madrigal Pharmaceuticals, Inc.. This represents a change in shares of -65.97% during the quarter. The current value of the position is $14,712,353 USD.

D. E. Shaw & Co., Inc. has a history of taking positions in derivatives of the underlying security (MDGL) in the form of stock options. The firm currently holds call options representing 77,700 of underlying shares valued at $40,673,619 USD and put options representing 19,500 of underlying shares valued at $10,207,665 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MDGL / Madrigal Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 30,139 -58,415 -65.97 15,777 -69.41 0.0070
2026-02-17 2025-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 88,554 -7,628 -7.93 51,569 16.90 0.0283
2025-11-14 2025-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 96,182 -15,799 -14.11 44,115 30.17 0.0249
2025-08-14 2025-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 111,981 12,975 13.11 33,890 3.34 0.0240
2025-05-15 2025-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 99,006 75,162 315.22 32,794 345.74 0.0292
2025-02-14 2024-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 23,844 23,844 7,358 0.0054
2024-11-14 2024-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 0 -947 -100.00 0 -100.00
2024-08-14 2024-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 947 -5,114 -84.38 265 -83.62 0.0002
2024-05-15 2024-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 6,061 -9,561 -61.20 1,619 -55.23 0.0014
2024-02-14 2023-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 15,622 9,708 164.15 3,615 318.77 0.0032
2023-11-14 2023-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 5,914 316 5.64 864 -33.26 0.0009
2023-08-14 2023-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 5,598 -19,340 -77.55 1,293 -78.60 0.0013
2023-05-15 2023-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 24,938 -128,500 -83.75 6,041 -86.44 0.0065
2023-02-14 2022-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 153,438 130,458 567.70 44,535 2,882.92 0.0492
2022-11-14 2022-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 22,980 799 3.60 1,493 -5.98 0.0018
2022-08-15 2022-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 22,181 -585 -2.57 1,588 -28.92 0.0019
2022-05-16 2022-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 22,766 -9,726 -29.93 2,234 -18.85 0.0021
2022-02-14 2021-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 32,492 -5,732 -15.00 2,753 -9.74 0.0023
2021-11-15 2021-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 38,224 16,812 78.52 3,050 46.21 0.0028
2021-08-16 2021-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 21,412 13,694 177.43 2,086 131.01 0.0018
2021-05-17 2021-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 7,718 3,901 102.20 903 112.97 0.0009
2021-02-16 2020-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 3,817 3,817 424 0.0004
2020-02-14 2019-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 0 -2,868 -100.00 0 -100.00
2019-11-14 2019-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 2,868 -5,759 -66.76 247 -72.68 0.0003
2019-08-14 2019-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 8,627 5,747 199.55 904 150.42 0.0011
2019-05-15 2019-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 2,880 2,880 361 0.0005
2018-11-14 2018-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 0 -1,200 -100.00 0 -100.00
2018-08-14 2018-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 1,200 -41,411 -97.18 336 -93.25 0.0004
2018-05-15 2018-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 42,611 17,619 70.50 4,977 116.96 0.0068
2018-02-14 2017-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 24,992 24,992 2,294 0.0032
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F MADRIGAL PHARMACEUTICALS COM Call 77,700 -0.13 40,674 -10.23 n/a n/a n/a
2026-02-17 2025-12-31 13F MADRIGAL PHARMACEUTICALS COM Call 77,800 44.34 45,306 83.27 n/a n/a n/a
2025-11-14 2025-09-30 13F MADRIGAL PHARMACEUTICALS COM Call 53,900 133.33 24,722 253.66 n/a n/a n/a
2025-08-14 2025-06-30 13F MADRIGAL PHARMACEUTICALS COM Call 23,100 3.12 6,991 -5.78 n/a n/a n/a
2025-05-15 2025-03-31 13F MADRIGAL PHARMACEUTICALS COM Call 22,400 -67.82 7,420 -65.45 n/a n/a n/a
2025-02-14 2024-12-31 13F MADRIGAL PHARMACEUTICALS COM Call 69,600 29.37 21,476 88.11 n/a n/a n/a
2024-11-14 2024-09-30 13F MADRIGAL PHARMACEUTICALS COM Call 53,800 19.82 11,417 -9.24 n/a n/a n/a
2024-08-14 2024-06-30 13F MADRIGAL PHARMACEUTICALS COM Call 44,900 -14.96 12,579 -10.78 n/a n/a n/a
2024-05-15 2024-03-31 13F MADRIGAL PHARMACEUTICALS COM Call 52,800 53.04 14,100 76.63 n/a n/a n/a
2024-02-14 2023-12-31 13F MADRIGAL PHARMACEUTICALS COM Call 34,500 40.82 7,983 123.15 n/a n/a n/a
2023-11-14 2023-09-30 13F MADRIGAL PHARMACEUTICALS COM Call 24,500 544.74 3,578 307.87 n/a n/a n/a
2023-08-14 2023-06-30 13F MADRIGAL PHARMACEUTICALS COM Call 3,800 0.00 878 -4.67 n/a n/a n/a
2023-05-15 2023-03-31 13F MADRIGAL PHARMACEUTICALS COM Call 3,800 921 n/a n/a n/a
2019-08-14 2019-06-30 13F MADRIGAL PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-15 2019-03-31 13F MADRIGAL PHARMACEUTICALS COM Call 13,800 0.00 1,729 11.12 n/a n/a n/a
2019-02-14 2018-12-31 13F MADRIGAL PHARMACEUTICALS COM Call 13,800 263.16 1,556 91.15 n/a n/a n/a
2018-11-14 2018-09-30 13F MADRIGAL PHARMACEUTICALS COM Call 3,800 814 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F MADRIGAL PHARMACEUTICALS COM Put 19,500 -28.57 10,208 -35.79 n/a n/a n/a
2026-02-17 2025-12-31 13F MADRIGAL PHARMACEUTICALS COM Put 27,300 10.53 15,898 40.33 n/a n/a n/a
2025-11-14 2025-09-30 13F MADRIGAL PHARMACEUTICALS COM Put 24,700 187.21 11,329 335.36 n/a n/a n/a
2025-08-14 2025-06-30 13F MADRIGAL PHARMACEUTICALS COM Put 8,600 1.18 2,603 -7.57 n/a n/a n/a
2025-05-15 2025-03-31 13F MADRIGAL PHARMACEUTICALS COM Put 8,500 0.00 2,815 7.36 n/a n/a n/a
2025-02-14 2024-12-31 13F MADRIGAL PHARMACEUTICALS COM Put 8,500 2,623 n/a n/a n/a
2024-11-14 2024-09-30 13F MADRIGAL PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-14 2024-06-30 13F MADRIGAL PHARMACEUTICALS COM Put 900 -90.11 252 -89.63 n/a n/a n/a
2024-05-15 2024-03-31 13F MADRIGAL PHARMACEUTICALS COM Put 9,100 2,430 n/a n/a n/a
2022-02-14 2021-12-31 13F MADRIGAL PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F MADRIGAL PHARMACEUTICALS COM Put 10,000 0.00 798 -18.07 n/a n/a n/a
2021-08-16 2021-06-30 13F MADRIGAL PHARMACEUTICALS COM Put 10,000 163.16 974 119.37 n/a n/a n/a
2021-05-17 2021-03-31 13F MADRIGAL PHARMACEUTICALS COM Put 3,800 444 n/a n/a n/a
2020-05-15 2020-03-31 13F MADRIGAL PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F MADRIGAL PHARMACEUTICALS COM Put 10,000 -50.00 911 -47.16 n/a n/a n/a
2019-11-14 2019-09-30 13F MADRIGAL PHARMACEUTICALS COM Put 20,000 -33.33 1,724 -45.17 n/a n/a n/a
2019-08-14 2019-06-30 13F MADRIGAL PHARMACEUTICALS COM Put 30,000 44.23 3,144 20.69 n/a n/a n/a
2019-05-15 2019-03-31 13F MADRIGAL PHARMACEUTICALS COM Put 20,800 92.59 2,605 114.05 n/a n/a n/a
2019-02-14 2018-12-31 13F MADRIGAL PHARMACEUTICALS COM Put 10,800 1,217 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.